Search clinical trials for: US-DARZALEX FASPRO®-Rd

Total 121 results

Shanghai Henlius Biotech

Recruiting

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM)

China, United States, Serbia, Australia, Georgia
Regeneron Pharmaceuticals

Recruiting

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM) (LINKER-SMM2)

High Risk Smoldering Multiple Myeloma (HR-SMM)

United States
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

Tumor

China
Genmab

Terminated

GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Acute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)

Philippines, United States, Australia, France, Netherlands, Czechia, New Zealand, Denmark, Spain, Sweden, Malaysia, Greece, Poland, Georgia, Bosnia and Herzegovina, Hungary, North Macedonia, Ukraine, South Korea, Moldova
Barry A. Boilson
Janssen Biotech, Inc.

Enrolling by invitation

Daratumumab in HLA Desensitization Prior to Transplantation

Cardiac Transplant

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe